Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference

Rhea-AI Summary

Castle Biosciences (NASDAQ: CSTL) said its executive management will present a company overview at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, Dec. 2, 2025 at 1:10 p.m. ET. A live audio webcast will be available at the company’s investor events page and a replay will be posted after the live broadcast.

News Market Reaction

+0.66%

1 alert

+0.66% News Effect

On the day this news was published, CSTL gained 0.66%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

FRIENDSWOOD, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Piper Sandler 37^th Annual Healthcare Conference on Tuesday, Dec. 2, 2025, at 1:10 p.m. Eastern time.

A live audio webcast of the Company’s presentation will be available by visiting Castle Biosciences’ website at ir.castlebiosciences.com/events-presentations/. A replay of the webcast will be available following the conclusion of the live broadcast.

About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.

We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Instagram, Facebook and X. 

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com

Source: Castle Biosciences Inc.

FAQ

When will Castle Biosciences (CSTL) present at the Piper Sandler 37th Annual Healthcare Conference?

Castle Biosciences will present on Dec. 2, 2025 at 1:10 p.m. ET.

How can investors listen to Castle Biosciences’ (CSTL) Piper Sandler presentation on Dec. 2, 2025?

Investors can access a live audio webcast at the company's investor events page: ir.castlebiosciences.com/events-presentations/.

Will a replay of Castle Biosciences’ (CSTL) Piper Sandler presentation be available after the event?

Yes, a replay of the webcast will be available following the conclusion of the live broadcast on the same investor events page.

What will Castle Biosciences (CSTL) cover in its Piper Sandler presentation on Dec. 2, 2025?

The company will deliver a company overview presented by executive management.

Where is Castle Biosciences headquartered and what is its Nasdaq ticker?

Castle Biosciences is headquartered in Friendswood, Texas and trades as CSTL on Nasdaq.